SCHEMBL17536624

SCHEMBL17536624

COc1ccc(C#C[Si](C)(C)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.46
KCNH2 Q12809 1/20 0.44
CA4 P22748 1/20 0.43
LTA4H P09960 2/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
NLRP3 Q96P20 1/20 0.41
TRPA1 O75762 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17553233 0.86 CYP1A2 (0.47) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL17553242 0.85 L3MBTL1 (0.41) CA4NPC1RAB9AMEN1KMT2A
SCHEMBL17536636 0.83 APP (0.48) APPKCNH2NPC1RAB9AMEN1
SCHEMBL17552564 0.80 ALDH1A1 (0.42) APPKCNH2NPC1RAB9AMEN1
SCHEMBL17552565 0.80 GRM5 (0.38) CA4NPC1RAB9AMEN1KMT2A
SCHEMBL6365168 0.79 APP (0.48) APPKCNH2NPC1RAB9AMEN1
SCHEMBL17552562 0.79 PYCR1 (0.37) APPNPC1RAB9AMEN1KMT2A
SCHEMBL17552567 0.79 GRM5 (0.37) APPNPC1RAB9AMEN1KMT2A
SCHEMBL673162 0.77 APP (0.55) APPKCNH2NPC1RAB9AMEN1
SCHEMBL15299057 0.77 APP (0.55) APPKCNH2NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3189063-B1 BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS CALIFORNIA INST OF TECHN (US) 2019-08-14 EP disclosed
US-10072030-B2 Base-catalyzed silylation of terminal alkyne C—H bonds CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2018-09-11 US disclosed
EP-3189063-A1 BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS California Institute of Technology (US) 2017-07-12 EP disclosed
US-20170088563-A1 BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS NATIONAL SCIENCE FOUNDATION 2017-03-30 US disclosed
US-9556206-B2 Base-catalyzed silylation of terminal alkyne C—H bonds CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-01-31 US disclosed
WO-2016036685-A1 BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-03-10 WO disclosed
WO-2016036685-A1 BASE-CATALYZED SILYLATION OF TERMINIAL ALKYNE C-H BONDS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-03-10 WO disclosed
US-20160060278-A1 BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS CALIFORNIA INSTITUTE OF TECHNOLOGY 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060278-A1 BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS ALKBH3, CA3, ALKBH2 APP 4614/4885KCNH2 12/4885CA4 21/4885
US-20170088563-A1 BASE-CATALYZED SILYLATION OF TERMINAL ALKYNE C-H BONDS ALKBH3, CA3, ALKBH2 APP 4664/4885KCNH2 10/4885CA4 25/4885
US-10072030-B2 Base-catalyzed silylation of terminal alkyne C—H bonds ALKBH3, CA3, ALKBH2 APP 4618/4885KCNH2 8/4885CA4 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.